7Baggers
 Ultragenyx (RARE) Poised for Positive Developments, Says JPMorga  GuruFocus Thu, 02 Oct 2025 11:30:48 GMT
 Ultragenyx placed on ‘Positive Catalyst Watch’ at JPMorgan  TipRanks Thu, 02 Oct 2025 11:29:18 GMT
 Mucopolysaccharidosis III Pipeline 2025: Pioneering Clinical  openPR.com Thu, 02 Oct 2025 00:08:02 GMT
 United States Osteogenesis Imperfecta Treatment Market  openPR.com Wed, 01 Oct 2025 12:13:19 GMT
 Ultragenyx appoints Eric Olson as chief business officer By Investing.com  Investing.com Nigeria Wed, 01 Oct 2025 07:00:24 GMT
 revolution medicines hires mirati, alx vet sandler  BioCentury Tue, 30 Sep 2025 23:43:00 GMT
 Ultragenyx appoints Eric Olson Chief Business Officer  TipRanks Tue, 30 Sep 2025 20:17:52 GMT
 adeno-associated virus (aav) vectors in gene therapy pipeline  openPR.com Mon, 29 Sep 2025 17:54:03 GMT
 published on: 2025-09-28 21:50:14  earlytimes.in Sun, 28 Sep 2025 16:20:14 GMT
 regeneron wins fda label expansion for evkeeza (regn:nasdaq)  Seeking Alpha Fri, 26 Sep 2025 11:32:47 GMT
 sanfilippo syndrome pipeline 2025: pioneering clinical  openPR.com Thu, 25 Sep 2025 16:38:04 GMT
 ultragenyx makes bid for dimension therapeutics - biotech movers  TheStreet Fri, 12 Sep 2025 03:38:10 GMT
 ions up on fda's breakthrough tag for ion582 in angelman syndrome  Zacks Investment Research Wed, 10 Sep 2025 14:32:51 GMT
 ultragenyx reports positive long-term data for gsdia gene therapy  Investing.com Tue, 09 Sep 2025 07:23:49 GMT
 rare reports positive long-term data from metabolic disorder study  Yahoo Finance Tue, 09 Sep 2025 07:00:00 GMT
 ultragenyx reports positive phase 3 gene therapy results  TipRanks Mon, 08 Sep 2025 07:00:00 GMT
 ultragenyx reports positive long-term data for gsdia gene therapy  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 ultragenyx svp huizenga sells $2.6k in shares  Investing.com Mon, 08 Sep 2025 07:00:00 GMT
 5 companies caught on a carousel of fda confusion  BioSpace Mon, 08 Sep 2025 04:05:59 GMT
 cantor fitzgerald remains a buy on ultragenyx pharmaceutical (rare)  The Globe and Mail Sat, 06 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 13:45:06  Newser Tue, 02 Sep 2025 18:45:06 GMT
 published on: 2025-09-01 02:49:16  Newser Mon, 01 Sep 2025 07:49:16 GMT
 published on: 2025-08-31 23:35:05  Newser Mon, 01 Sep 2025 04:35:05 GMT

Ultragenyx Pharmaceutical Inc
(NASDAQ:RARE) 

RARE stock logo

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibod...

Founded: 2010
Full Time Employees: 740
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends